POLYTECH Health & Aesthetics GmbH, a global leader in breast aesthetics, this week announced the market introduction of an expanded B-Lite® range, the world’s first and only lightweight breast implants.
POLYTECH claims that their B-Lite® breast implants, which are up to 30% lighter, have many unique advantages for women, with reported quicker recovery and reduced post-operative pain, enabling patients to resume their daily routine more quickly. The expanded range includes additional shapes and surfaces – B-Lite® with MESMO® fine-texturing surface and B-Lite® with the unique Microthane® shell coating.
“As the aesthetic market adjusts to the ‘new normal’, POLYTECH is increasing our R&D efforts and our investment in the future of our industry. We are offering women and surgeons the first true innovation in breast aesthetics in nearly 30 years.” stated Wolfgang Steimel, POLYTECH CEO. Mr. Steimel added: “B-Lite® is proven to reduce pressure on breast tissue by up to 50%. Whether for augmentation or reconstruction, women want to have beautiful breasts over time, but they don’t want the extra weight. Our new range now offers this unique advantage across every implant surface”.
Polytech has designed the B-Lite® range to maintain beautiful, natural looking breasts over time. B-Lite® implants are claimed to reduce the long-term unwanted impact of implant weight and pressure on the breast tissue. This reduces the impact of gravity as the female breasts age, reduce the dynamic forces on the breast tissues resulting in less stretching from movement and therefore providing greater daily comfort.
With B-Lite®, patients can have the desired increased breast volume with less total weight.
“We are really excited about the opportunity B-Lite® offers women. In breast reconstruction you are treating women with already compromised breast tissue. By reducing weight and pressure caused by traditional implants, the new B-Lite® breast implants can offer new possibilities for reconstruction patients, potentially reducing recovery time, unwanted complications and unnecessary re-operations” stated Prof. Moustapha Hamdi, MD, PhD, Chairman of Plastic and Reconstructive Surgery at the Brussels University Hospital.
With a global footprint in over 80 countries, POLYTECH Health & Aesthetics GmbH employs over 280 people and specialise in the development and production of silicone implants. Founded in 1986 in Dieburg, Germany, the company focuses on breast implants, used in both reconstructive and aesthetic plastic surgery. POLYTECH is the only German manufacturer of soft tissue implants. All products are developed exclusively at the company headquarters in Germany.